Svmuu News: Robinhood's board of directors approved a $1.5 billion share buyback plan on Tuesday. Robinhood's Chief Financial Officer, Shiv Verma, stated that this authorization reflects the management and board's confidence in continuously launching innovative products for customers and creating value for shareholders.
The company indicated it expects to execute this $1.5 billion authorization over approximately the next three years, while retaining the flexibility to accelerate buybacks when market conditions permit. Previously, the board approved a $1 billion buyback plan in May 2024 and an additional $500 million plan in April 2025.
In recent years, Robinhood has increased its focus on crypto business, including promoting 24/7 on-chain stock trading and offering tokenized exposure to large private companies for non-U.S. customers; its Arbitrum-based Ethereum Layer 2 network, Robinhood Chain, has already launched its testnet. (The Block)
Robinhood Board Approves $1.5 Billion Share Buyback Plan
Source:Odaily · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
Billionaire investor Chase Coleman’s Tiger Global fund disclosed in its latest 13F filing that its top five growth stocks are all focused on AI infrastructure, including TSMC, NVIDIA, Amazon, Meta, and Google.
-
2
Will the BEAM token go to zero? Could it rise to $1,000? An in-depth analysis of the Beam network and its market prospects
-
3
What Is CVP? An In-Depth Analysis of the PowerPool Ecosystem and the Investment Value of Its Token, CVP
-
4
Analysis of CRYSTAL’s Value and Investment Potential: An Examination of Multiple Projects and Risk Assessment
-
5
Analysis: The State Street Healthcare ETF (XLV) has an expense ratio of 0.08% and a diversified portfolio, while the Invesco Biotechnology ETF (PBE) has an expense ratio of 0.58% and focuses on small-cap stocks; PBE is up 10.2% year-to-date, outperforming XLV.
-
6
QUARTZ Coin Analysis: An Overview of the Sandclock (QUARTZ) and Unique Network’s Quartz (QTZ) Projects
-
7
Ethereum Recent Rebound: Price Breaks Above $1,970, but Multiple Risks Remain
-
8
What Is JGN? Analysis of the JGN (Sword Saint Coin) Project’s Positioning, Features, and Value
-
9
NVIDIA and AMD: The Two Giants of AI Computing Power in 2026—An Analysis of Market Dynamics, Financial Performance, and Opportunities for Transition into Cryptocurrency Mining
-
10
Analysis Compares Healthcare ETFs: Invesco Nasdaq Biotech ETF (IBBQ) Saw 45.5% One-Year Return, Outperforming State Street Healthcare Select Sector SPDR ETF (XLV)
Markets Today
Recommended Reading









